volume 27, issue 3, P311-315 2013
DOI: 10.3109/02688697.2012.752432
View full text
|
|
Share
R. Ma, N. de Pennington, M. Hofer, C. Blesing, R. Stacey

Abstract: Gliomas are the most common primary central nervous system tumour seen in adults. There have been many advances over the last two decades as we widen our search for a molecular basis of gliomagenesis. Many biomarkers have been discovered to be important in the management of gliomas, including 1p19q co-deletion, MGMT promoter methylation, BRAF and IDH1 mutations. In this review, we attempt to summarise the available literature on these biomarkers and their use in the diagnosis and management of gliomas. We pay …

expand abstract